ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans

Taispeáin leaganacha eile (1)

The induction of cellular immunity, in conjunction with antibodies, may be essential for vaccines to protect against blood-stage infection with the human malaria parasite Plasmodium falciparum. We have shown that prime-boost delivery of P. falciparum blood-stage antigens by chimpanzee adenovirus 63...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sheehy, S, Duncan, C, Elias, S, Choudhary, P, Biswas, S, Halstead, F, Collins, K, Edwards, N, Douglas, A, Anagnostou, N, Ewer, K, Havelock, T, Mahungu, T, Bliss, C, Miura, K, Poulton, I, Lillie, P, Antrobus, R, Berrie, E, Moyle, S, Gantlett, K, Colloca, S, Cortese, R
Formáid:	Journal article
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2012)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2012)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2011)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
de réir: Elias, S, et al.
Foilsithe / Cruthaithe: (2014)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals.
de réir: Hodgson, S, et al.
Foilsithe / Cruthaithe: (2014)

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals
de réir: Hodgson, SH, et al.
Foilsithe / Cruthaithe: (2014)

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2010)

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1
de réir: Sheehy, S, et al.
Foilsithe / Cruthaithe: (2011)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
de réir: Ogwang, C, et al.
Foilsithe / Cruthaithe: (2013)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
de réir: Kimani, D, et al.
Foilsithe / Cruthaithe: (2014)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
de réir: Bliss, C, et al.
Foilsithe / Cruthaithe: (2016)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
de réir: O'Hara, G, et al.
Foilsithe / Cruthaithe: (2012)

A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
de réir: De Barra, E, et al.
Foilsithe / Cruthaithe: (2014)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
de réir: Caroline Ogwang, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
de réir: Ewer, K, et al.
Foilsithe / Cruthaithe: (2013)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
de réir: Biswas, S, et al.
Foilsithe / Cruthaithe: (2014)

Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I first-in-human trial
de réir: de Graaf, H, et al.
Foilsithe / Cruthaithe: (2021)

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
de réir: Rampling, T, et al.
Foilsithe / Cruthaithe: (2016)

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine chad63-mva rh5 in a phase ia clinical trial
de réir: Payne, R, et al.
Foilsithe / Cruthaithe: (2017)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
de réir: Mensah, V, et al.
Foilsithe / Cruthaithe: (2016)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
de réir: Morter, R, et al.
Foilsithe / Cruthaithe: (2022)

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
de réir: Victorine A Mensah, et al.
Foilsithe / Cruthaithe: (2016-01-01)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
de réir: Tiono, AB, et al.
Foilsithe / Cruthaithe: (2018)

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.
de réir: Lillie, P, et al.
Foilsithe / Cruthaithe: (2012)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2009)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
de réir: Bliss, C, et al.
Foilsithe / Cruthaithe: (2018)

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
de réir: Rampling, T, et al.
Foilsithe / Cruthaithe: (2018)

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALARIA CHALLENGE IN HEALTHY MALARIA-NAIVE VOLUNTEERS
de réir: Duncan, C, et al.
Foilsithe / Cruthaithe: (2010)

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
de réir: Richard Morter, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.
de réir: Duncan, C, et al.
Foilsithe / Cruthaithe: (2011)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
de réir: Rampling, T, et al.
Foilsithe / Cruthaithe: (2015)

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119
de réir: Rocha, M, et al.
Foilsithe / Cruthaithe: (2017)

Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo
de réir: Ewer, K, et al.
Foilsithe / Cruthaithe: (2018)

Genetic diversity in two leading Plasmodium vivax malaria vaccine candidates AMA1 and MSP119 at three sites in India.
de réir: Sonal Kale, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Planning for innovation through dissemination and utilization of knowledge /
de réir: Havelock, Ronald G.
Foilsithe / Cruthaithe: (1976)

The Cosmic Myths of Homer and Hesiod
de réir: Eric A. Havelock
Foilsithe / Cruthaithe: (1987-01-01)

The Alphabetic Mind: A Gift of Greece to the Modern World
de réir: Eric A. Havelock
Foilsithe / Cruthaithe: (1986-01-01)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
de réir: Ewer (nee Russell), K, et al.
Foilsithe / Cruthaithe: (2016)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
de réir: Capone, S, et al.
Foilsithe / Cruthaithe: (2010)